期刊文献+

干扰素γ对丙型肝炎病毒复制子的抑制作用 被引量:1

The direct antiviral effect of interferon-γ on hepatitis C virus repiicon
原文传递
导出
摘要 目的研究干扰素(IFN)γ直接抑制丙型肝炎病毒(HCV)复制子的作用及其与IFN α联合用药的疗效,并对可能介导IFN γ抗HCV作用的干扰素刺激基因(ISG)的表达水平进行探讨。方法建立HCV复制子细胞模型,用IFN γ或IFN γ联合IFN α处理HCV复制子细胞,通过半定量逆转录聚合酶链反应(RT-PCR)及实时定量PCR检测细胞中HCV RNA水平;western blot检测细胞中HCV非结构蛋白5A(NS5A)。结果 IFN γ对HCV RNA的复制及NS5A的表达有明显抑制作用,10 U/ml IFN γ可使 HCV RNA较对照组减少36%,25 U/ml减少80%;IFN γ对HCV RNA及NS5A蛋白的抑制作用与其剂量及作用时间呈正相关。用IFN γ预处理的细胞对IFN α抗HCV的作用更敏感,且细胞内干扰素调节因子 -l(IRF-1)、干扰素刺激基因因子3 γ(ISGF3 γ)和2’5’-寡腺苷酸合成酶(2’5’-OAS)呈明显的诱导性表达。结论 IFN γ能有效抑制HCV RNA的复制,并与IFN α有协同抗HCV的作用。IRF-1、ISGF3 γ和2’5’-OAS可能参与介导IFN γ抗HCV的作用。 Objectives To study the effects of interferon-γ and interferon-γ combined with interferon-α on HCV RNA replication and the possible mediators of interferon-γ anti-HCV in vitro. Methods An HCV replicon cell culture system was established and the cells were treated with interferon-γ or interferon-γ combined with interferon-α. HCV RNA levels in the cells were evaluated by semi-quantitative RT-PCR and real-time PCR, and the levels of NS5A protein were examined by Western blot. Results Interferon-γ could inhibit HCV RNA replication and NS5A protein expression effectively; The anti-HCV effects of interferon-γ were both in time-dependent and does-dependent manners; Pretreating the cells with interferon-γ could significantly enhance the antiviral effects of interferon-α; The expressions of IRF-1, 2'5'-OAS1(p46), 2'5'-OAS2(p69), ISGFγ/and STAT1 were significantly increased after interferon-γ treatment. Conclusion Interferon-γ has a direct inhibitory effect on HCV replicon RNA replication and NS5A expression, and both are in a dose and time dependent manner; Interferon-γ has a synergistic anti-HCV effect with interferon-α. IRF-1,2'5'-OAS1(p46), 2'5'-OAS2(p69) and ISGF3γ may mediate the anti-HCV effects of interferon-γ.
出处 《中华肝脏病杂志》 CAS CSCD 北大核心 2006年第1期7-10,共4页 Chinese Journal of Hepatology
基金 国家自然科学基金(30170844)国家"十五"攻关项目(200lBA705B06 2004BA718B10)
关键词 干扰素Ⅱ型 肝炎病毒 丙型 复制子 Interferon type Ⅱ Hepatitis C virus Replicon
  • 相关文献

参考文献1

二级参考文献16

  • 1丙型肝炎防治指南[J].临床肝胆病杂志,2004,20(4):197-203. 被引量:735
  • 2贾因棠,魏来.丙型肝炎病毒非结构基因复制子模型的建立和应用[J].中华肝脏病杂志,2005,13(2):158-160. 被引量:2
  • 3Pestka S, Langer JA, Zoon KC, et aL lntefferons and their actions.Annu Rev Biochem, 1987, 56: 727-777.
  • 4Global surveillance and control of hepatitis C. Report of a WHO consultation organized in coUabomtion with the viral hepatitis C prevention board, Antwerp, Belgium J Viral Hepatol, 1999, 6 : 35-47.
  • 5McHutchison JG, Poynard T. Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C. Semin Liver Dis, 1999, 19:57-65.
  • 6Moradpour D, Blum HE. Current and evolving therapies for hepatitis C. Eur Gastroenterol Hepatol, 1999, 11 : 1199-1202.
  • 7Luxon BA, Grace M, Brassard D, et al. Pegylated interferons for the treatment of chronic hepatitis C infection. Clin Ther, 2002, 24:1363-1383.
  • 8Lohamnn V, Komer F, Koch JO, et al Repliction of subgenomic hepatitis C virus RNA in a hepatoma cell line. Science, 1999, 285 :110-113.
  • 9Blight K J, Kolykhalov AA, Rice CM. Efficient initiation of HCV RNA replication in cell culture. Science, 2000, 290: 1972-1974.
  • 10Horscroft N, Lai VC, Cheney W, et al. Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus.Anfivir Chem Chemother, 2005,16 : 1-12.

共引文献6

同被引文献23

  • 1张平安,吴健民,李艳.干扰素γ基因内含子1+874位点多态性与乙型肝炎病毒感染关系的研究[J].中华流行病学杂志,2006,27(1):41-43. 被引量:13
  • 2王坤,时昌文,高勇,于振海,宁涛,曹邦伟,李勇.中国北方两市部分人群IL-2、IL-4基因多态性与乙肝关联性的研究[J].中国现代普通外科进展,2006,9(3):171-173. 被引量:3
  • 3Cecile G, Heiene C, Jerome C, et al. Lethal Hepatitis After Gene Transfer of IL - 4 in the Liver Is Independent of Immune Responses and Dependent on Apoptosis of Hepatoeytes: A Rodent Model of IL- 4- lndueed Hepatitis[J ]. The Journal of Immunology, 2001, 166 (8): 5225- 5235.
  • 4Rosenwasser LJ, Klemm DJ, Dresback JK, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy[J ]. Clin Exp Allergy,1995, 25(S) :74 - 78.
  • 5Gramenzi A, Andreoe P, Loggi E, et al. Cytokine profile of periph eral blood mononuelear eells from patients with different outeomes of hepatitis C virus infeetion[J ]. Journal of Viral Hepatitis, 2005,12(5) : 525 - 534.
  • 6Barrett S, Collins M, Kenny C, et al. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin - 6, interferongamma, and outcome of hepatitis C virus infection[J]. J Med Virol, 2003, 71(2): 212- 218.
  • 7Miyazoe S, Hamasaki K, Nakata K, et al. Influence of interleukine- 10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus [J ]. Am J Gastroenterol, 2002, 97(8): 2086- 2092.
  • 8Domenico L, Calogero C, Rosa DS, et al. IL- 10 and TNF- ? Polymorphisms and Recovery from HCV Infection[J]. Human Immunology, 2003, 64(7): 674-680.
  • 9Vidigal PG, Germer J J, Zein NN. Polymorphisms in the interleukine- 10, tumor necrosis factor - alpha, and transforming growth factor-betal gene in chronic hepatitis C patients treated with interferon and ribavirin[J]. J Hepatol, 2002, 36(2): 271- 277.
  • 10Hohler T, Kruger A, Gerken G, et al. A tumor necrosis factor- a (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection[J]. Clin Exp Immunol, 1998, 111(3): 579-582.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部